Facebook Twitter LinkedIn Google Plus RSS

Cyclacel Pharmaceuticals announces proposed stock offering

By ,

Cyclacel Pharmaceuticals Inc. on Wednesday announced it is offering to sell, subject to market and other conditions, shares of its common stock in an underwritten offering.

In the announcement, Cyclacel, in Berkley Heights, said it also expects to grant the underwriters a 30-day option to purchase additional shares of common stock to cover overallotments, if any. Further terms were not disclosed.

Also Popular on NJBIZ

Write to the Editorial Department at editorial@njbiz.com

Leave a Comment


Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy